Skip to main content
. 2012 Nov 27;11(1):61–75. doi: 10.2165/11588270-000000000-00000

Fig. 1.

Fig. 1

Subject randomization and analysis populations. Two randomized subjects in part A were not treated and were withdrawn from the study for the following reported reasons: ‘high blood pressure pre-dose’ and ‘poor vein conditions’. AE = adverse event; PV = protocol violation; VCS = valid cases set for pharmacokinetic and pharmacodynamic analyses.